Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer

Globally, gastric cancer is the second leading cause of cancer deaths because of the lack of effective treatments for patients with advanced tumors when curative surgery is not possible. Thus, there is an urgent need to identify molecular targets in gastric cancer that can be used for developing nov...

Full description

Saved in:
Bibliographic Details
Published in:Am J Cancer Res
Main Authors: Yin, Yuping, Shen, Qian, Zhang, Peng, Tao, Ruikang, Chang, Weilong, Li, Ruidong, Xie, Gengchen, Liu, Weizhen, Zhang, Lihong, Kapoor, Prabodh, Song, Shumei, Ajani, Jaffer, Mills, Gordon B, Chen, Jianying, Tao, Kaixiong, Peng, Guang
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385637/
https://ncbi.nlm.nih.gov/pubmed/28401005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items